- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/55 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Patent holdings for IPC class A61K 47/55
Total number of patents in this class: 1429
10-year publication summary
11
|
42
|
77
|
140
|
153
|
162
|
188
|
273
|
249
|
66
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Purdue Research Foundation | 3277 |
36 |
Dana-Farber Cancer Institute, Inc. | 2455 |
35 |
Yale University | 2204 |
32 |
Sapreme Technologies B.V. | 74 |
32 |
The Regents of the University of California | 18943 |
25 |
Arvinas Operations, Inc. | 165 |
19 |
Kymera Therapeutics, Inc. | 175 |
15 |
Zevra Therapeutics, Inc. | 85 |
14 |
University of Southern California | 2016 |
13 |
Charite - Universitatsmedizin Berlin | 369 |
10 |
Elysium Therapeutics, Inc. | 16 |
9 |
Endocyte, Inc. | 113 |
9 |
University of Massachusetts | 2130 |
9 |
Imbria Pharmaceuticals, Inc. | 60 |
9 |
Diverse Biotech, Inc. | 16 |
9 |
Uppthera Inc. | 11 |
9 |
Wisconsin Alumni Research Foundation | 3774 |
8 |
Elucida Oncology, Inc. | 12 |
8 |
Icahn School of Medicine at Mount Sinai | 859 |
8 |
Ripple Therapeutics Corporation | 33 |
8 |
Other owners | 1112 |